Pancreatic Carcinoma
- 13 February 1992
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 326 (7), 455-465
- https://doi.org/10.1056/nejm199202133260706
Abstract
EVERY year, 112,000 Americans die of gastrointestinal cancer, and carcinoma of the pancreas accounts for 22 percent of these deaths.1 It is a disease with an extremely poor prognosis: fewer than 20 percent of affected patients survive the first year, and only 3 percent are alive five years after the diagnosis.2 In fact, of more than 60 cancer sites surveyed for the Annual Cancer Statistics Review, pancreatic carcinoma is the one with the lowest five-year survival rate.2 Despite this grim outcome, considerable progress has been made in our understanding of the pathogenesis of the disease, our ability to diagnose . . .Keywords
This publication has 142 references indexed in Scilit:
- Pylorus preserving pancreatoduodenectomy: An overviewBritish Journal of Surgery, 1990
- Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of VaterBritish Journal of Surgery, 1990
- Experience with 647 Consecutive Tumors of the Duodenum, Ampulla, Head of the Pancreas, and Distal Common Bile DuctAnnals of Surgery, 1989
- Clinicopathologic Analysis of Endoscopic Ultrasonograms in Pancreatic Mass LesionsEndoscopy, 1989
- Carcinoma of the exocrine pancreas: A sex hormone responsive tumour?British Journal of Surgery, 1987
- Serum immunoreactive elastase in diagnosis of pancreatic diseasesDigestive Diseases and Sciences, 1987
- Pyloric and Gastric Preserving Pancreatic ResectionAnnals of Surgery, 1986
- Regional Pancreatectomy for Cancer of the Pancreas, Ampulla, and Other Related SitesAnnals of Surgery, 1984
- Galactosyltransferase Isoenzyme II in the Detection of Pancreatic Cancer: Comparison with Radiologic, Endoscopic, and Serologic TestsNew England Journal of Medicine, 1981
- Coffee and Cancer of the PancreasNew England Journal of Medicine, 1981